Combined with the observation that DGKα promotes tumor metastasis by directly activating the FAK/AKT pathway [40], the results of the present study augmented the evidence that the DGKα/FAK axis contributes to ESCC progression in the context of the TME. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.